DOSSIER · 13F Holders · Q4 2025
AVADEL PHARMACEUTICALS
2 institutions still hold AVADEL PHARMACEUTICALS as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 05337M104·2 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
2 institutions reported AVADEL PHARMACEUTICALS in Q4 2025. Knoll Capital Management, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.